0001209191-19-049420.txt : 20190913 0001209191-19-049420.hdr.sgml : 20190913 20190913122624 ACCESSION NUMBER: 0001209191-19-049420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190912 FILED AS OF DATE: 20190913 DATE AS OF CHANGE: 20190913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wilson Jason Douglas CENTRAL INDEX KEY: 0001662395 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 191092032 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-12 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662395 Wilson Jason Douglas 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 0 1 0 0 Executive VP of Operations Employee Stock Option (right to buy) 11.62 2019-09-12 4 M 0 7350 0.00 D 2023-06-15 Class B common stock 7350 13881 D Class B common stock 2019-09-12 4 M 0 7350 11.62 A Class A common stock 7350 50996 D The options vested in twenty equal quarterly installments beginning on September 15, 2013. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date. /s/ Michael D. Wortley, attorney-in-fact 2019-09-13